YEREVAN. – Within the framework of the COVAX FACILITY initiative, Armenia has imported 24,000 doses of the British-Swedish AstraZeneca vaccine against the coronavirus. Gayane Sahakyan, head of the immunization program of the Ministry of Health, on Monday told about this to reporters.

According to her, the work with the aforesaid initiative continues, and other vaccines also will be offered to Armenia in the near future.

The vaccine will be available in all provinces of the country.

It does not require considerable storage conditions.

Vaccinations are scheduled to begin next week.

According to the expert, one dose of this vaccine costs about $25 in the international market, but within the framework of the COVAX FACILITY initiative, it was purchased for about $4.5.

As per Sahakyan, the clinical trials of this vaccine have been completed, and it has a World Health Organization (WHO) license to be used in emergencies.

According to the specialist, this vaccine is injected in two doses, at intervals of 8-12 weeks, for people over 18 years old.

As per Gayane Sahakyan, no serious post-vaccination side effects of the AstraZeneca vaccine have been recorded.